New Key Statistics Module, Z-Score and F-Score
NYSE:TEVA Key Ratios
| Market Cap $ M | 19,065.07 |
| Enterprise Value $ M | 36,012.07 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 6.38 |
| Forward PE Ratio | 5.43 |
| Price/Book | 2.63 |
| Price/Sales | 1.19 |
| Price/Free Cash Flow | 21.41 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 16,003.00 |
| EPS (TTM) $ | -0.41 |
| Beneish M-Score | -2.38 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 193.61 |
| EV-to-EBITDA | 27.55 |
| PEG | -- |
| Shares Outstanding M | 1,132.64 |
| Net Margin (%) | -3.08 |
| Operating Margin % | 20.79 |
| Pre-tax Margin (%) | -5.21 |
| Quick Ratio | 0.61 |
| Current Ratio | 0.89 |
| ROA % (ttm) | -1.15 |
| ROE % (ttm) | -6.73 |
| ROIC % (ttm) | 8.37 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.23 |
TEVA Number of Guru Trades
TEVA Volume of Guru Trades
Gurus Latest Trades with NYSE:TEVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:TEVA is held by these investors
Total 2
Teva Pharmaceutical Industries Ltd Insider Transactions
No Available Data
News about NYSE:TEVA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers